http://www.outlooktherapeutics.com
Outlook Therapeutics, Inc. Company Intro
NEWS JULY 17, 2020
Outlook Therapeutics Announces Closing of $1.0 Million Private Placement Priced At-The-Market Under Nasdaq Rules More JULY 7, 2020
Outlook Therapeutics Completes Patient Enrollment for NORSE 2 Study of ONS-5010 / LYTENAVA™ (bevacizumab-vikg) More
Industry
Healthcare
Outlook Therapeutics, Inc. Headquaters
7 Clarke Drive
Cranbury,08512
United States
Outlook Therapeutics, Inc. Share price
14 Sep 2022 09:57 GMT
$1.1600
0.04 (3.57 %)
Outlook Therapeutics, Inc. Market cap
$264.628 M
WMC RANKING
2022
Outlook Therapeutics, Inc. # 192
BiotechnologyLatest Outlook Therapeutics, Inc. News
06 Dec 2022
Allogene Therapeutics Inc. (NASDAQ: ALLO) Shares Could ...
Forecasts for the next quarter put sales growth at 56.90%. Allogene Therapeutics Inc. earnings are expected to increase by 9.00% in 2022, but the outlook is...
06 Dec 2022
Intellia Therapeutics Inc. (NASDAQ: NTLA) Stock Forecast: By ...
Intellia Therapeutics Inc. earnings are expected to increase by -57.60% in 2022, but the outlook is positive 30.00% per year for the next five years.
06 Dec 2022
Future Outlook And Stock Price Trends Among Nektar ...
Nektar Therapeutics stock is held by 321 institutions, with Invesco Ltd. being the largest institutional investor. By Jun 29, 2022, it held 19.87% of the shares...
WMC Market Score
WMC Market to Revenue Score
Outlook Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Outlook Therapeutics, Inc. | USD | $0 | $48,605 | $-40,499 | $2,646M | 192 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Outlook Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Post vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Outlook Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Outlook Therapeutics, Inc. | 0.07 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
